Wikidata

(Q44995575)

English

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

scientific article

In more languages

Statements

title
Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15277403
retrieved
8 December 2017
author name string
Mirja Tiikkainen
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15277403
retrieved
8 December 2017
Elena Korsheninnikova
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15277403
retrieved
8 December 2017
Tuulikki Nyman
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15277403
retrieved
8 December 2017
Sari Mäkimattila
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15277403
retrieved
8 December 2017
publication date
1 August 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15277403
retrieved
8 December 2017
page(s)
2169-2176
1 reference
stated in
Europe PubMed Central
PubMed ID
15277403
retrieved
8 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44995575&oldid=2060744773"